Biological Matrix vs. ADM vs. Synthetic Mesh: How Surgeons Choose

When a surgeon reinforces a breast implant, they typically choose from three broad categories of support material: a biological matrix, an acellular dermal matrix (ADM), or a synthetic mesh. The names are often used loosely, and the differences matter. This guide explains how the three compare and the factors surgeons weigh when choosing between them.

The three options at a glance

All three materials do the same basic job — supporting and defining the implant pocket — but they behave very differently once inside the body.

Biological matrix (xenograft, e.g. bovine pericardium)

A biological matrix is a processed collagen scaffold, often derived from animal tissue such as bovine pericardium. The living cells are removed, leaving a natural framework that the patient’s own cells and blood vessels can grow into. The goal is genuine integration — the graft becomes part of living, vascularised tissue rather than remaining a foreign object. Because the source tissue is consistent and manufactured to specification, quality can be uniform batch to batch.

Acellular dermal matrix (ADM)

ADM is a biological matrix made specifically from dermis (skin’s connective-tissue layer), either human- or animal-derived. It is the most established biological option and has a large body of clinical experience behind it. Considerations can include cost, and — for human-derived ADM — dependence on donor tissue supply, which can introduce batch-to-batch variability.

Synthetic mesh

Synthetic mesh is a manufactured polymer scaffold. It is predictable, readily available and generally lower cost. The trade-off is that it is a foreign material: some meshes are permanent and others slowly absorb, but none integrate into living tissue the way a biological scaffold does. For some patients and techniques that is perfectly acceptable; for others, biological integration is preferred.

What surgeons actually weigh

The “best” material depends on the patient and the plan, not on a universal ranking. Surgeons typically consider:

• Integration vs. permanence. Is it better for this patient to have a scaffold the body incorporates, or a stable permanent support?
• Strength and the planned technique. Prepectoral reconstruction places the implant above the muscle and leans heavily on the matrix, so mechanical strength matters more.
• Soft-tissue quality. Thin skin flaps may call for a material that adds reinforcement and integrates well.
• Consistency and availability. A manufactured xenograft can offer more uniform quality than donor-dependent tissue.
• Cost and reimbursement. These vary by material and by country.

A word on terminology

Part of what makes this comparison confusing is that the terms overlap. ADM is a biological matrix — specifically one made from dermis. So the real distinction is not “biological matrix vs. ADM” as two separate things, but rather which kind of biological matrix: a dermal one (ADM) or a non-dermal xenograft such as bovine pericardium. Synthetic mesh sits in a genuinely different category because it is not biological at all. Keeping this straight helps when you are comparing what different surgeons or manufacturers describe, because the same word can be used for quite different products.

How integration actually differs

The most important practical difference between these materials is what happens after implantation. A biological scaffold — whether dermal or pericardial — is designed to be repopulated by the patient’s own cells and blood vessels, so it is gradually remodelled into living, incorporated tissue. Synthetic mesh does not do this: it remains a manufactured object that the body encapsulates rather than integrates. Neither behaviour is automatically “right.” Integration is generally desirable when the aim is for the reconstruction to become part of the patient’s own tissue, while a permanent synthetic support may be chosen for other reasons. Understanding this difference is often more useful than any single ranking of the materials.

Cost, availability and consistency

Beyond biology, practical factors shape the choice. Human-derived ADM depends on donor tissue, which can affect supply and introduce batch-to-batch variability. A manufactured xenograft such as bovine pericardium is produced to a defined specification, which tends to make its properties more uniform. Synthetic mesh is usually the most readily available and lowest cost. Reimbursement and regulatory approval also vary by country, so what is practical in one health system may differ in another — a reason these decisions are made locally, with the surgeon.

Where biological matrices fit the modern trend

The broad direction of reconstruction has been toward biology-led, muscle-sparing techniques — and that has increased interest in matrices that both support the implant and integrate with the body. A robust, integrating scaffold such as a bovine-pericardium matrix suits this direction well, which is the thinking behind Advanced Biomedical Concept’s ExaShape. This matters most in prepectoral reconstruction, where the matrix carries more of the support role. For the deeper clinical comparison, see our pillar page: Biological Matrix vs. ADM vs. Synthetic Mesh, and the foundational biological matrix guide.

The bottom line

There is no single winner among biological matrix, ADM and synthetic mesh — each has a role, and the right choice is a clinical decision matched to the patient, the technique and local factors. What has changed is that biological matrices designed for genuine integration, and manufactured to consistent quality, have expanded what surgeons can achieve, particularly in muscle-sparing reconstruction. Explore ExaShape or read more about the technology behind modern reconstruction.

This article is for general education and is not medical advice. Material choices should be discussed with your reconstructive surgeon.